These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3162627)

  • 1. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
    Hartinger A; Korting HC; Neubert U; Blaufuss H
    Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of ofloxacin against Chlamydia trachomatis.
    Schachter J; Moncada JV
    Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Minimum inhibitory concentration and minimum bactericidal concentration of tetracycline and erythromycin in 35 recent Munich isolates of Chlamydia trachomatis].
    Korting HC; Hartinger A
    Hautarzt; 1988 Mar; 39(3):161-5. PubMed ID: 3378887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
    Catalan F; Milovanovic A; Prouteau C; Soulignac M
    Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
    Joly-Guillou ML; Bergogne-Berezin E
    Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin: therapeutic results in Chlamydia trachomatis urethritis.
    Bischoff W
    Infection; 1986; 14 Suppl 4():S316-7. PubMed ID: 3546156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genital chlamydia infections--clinical aspects, diagnosis and therapy].
    Korting HC; Hartinger A
    Urologe A; 1987 Sep; 26(5):256-62. PubMed ID: 3318084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with ofloxacin (RU 43280) of uncomplicated bacterial urethritis in males].
    Morel P; Casin I; Bianchi A; Dolivo M; Perol Y
    Pathol Biol (Paris); 1986 May; 34(5):502-4. PubMed ID: 3534731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
    Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
    Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
    Bai H; Dong J; Ning B
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of roxithromycin against Chlamydia trachomatis.
    Moroni A; Sambri V; Rumpianesi F; Donati M; Cevenini R
    J Chemother; 1991 Jan; 3 Suppl 1():28-9. PubMed ID: 12041779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women.
    Nayagam AT; Ridgway GL; Oriel JD
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():155-8. PubMed ID: 3182459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.
    Somani J; Bhullar VB; Workowski KA; Farshy CE; Black CM
    J Infect Dis; 2000 Apr; 181(4):1421-7. PubMed ID: 10762573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
    Børsum T; Dannevig L; Størvold G; Melby K
    Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fluoroquinolones in sexually transmitted diseases.
    Tartaglione TA; Hooton TM
    Pharmacotherapy; 1993; 13(3):189-201. PubMed ID: 8321733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious distribution and resistant of Neisseria gonorrhoeae, Mycoplasma, and Chlamydia trachomatis in the chronic prostatitis].
    Cao W; Liu L; Tong MH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):177-9. PubMed ID: 12934372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of quinolones in chlamydial infection.
    Oriel JD
    Rev Infect Dis; 1989; 11 Suppl 5():S1273-6. PubMed ID: 2672254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.